Oral Abstract Session 01 - Global HIV Vaccine Enterprise
Oral Abstract Session 01 - Global HIV Vaccine Enterprise
Oral Abstract Session 01 - Global HIV Vaccine Enterprise
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Topic 5: <strong>HIV</strong> Transmission and Viral Diversity<br />
P05.03<br />
Low Selection Rate of HLA-Anchor Escape Mutations<br />
in <strong>HIV</strong> After Transmission of Subtype B and<br />
Recombinants BF Strains Patients from Argentina<br />
G. Damilano 1 , E. Socias 2 , C. Magneres 2 , G. Turk 1 , M. Gomez-<br />
Carrillo 1 , H. Salomon 1 , D. Dilernia 1<br />
1 Argentinean Reference Center for AIDS, Buenos Aires,<br />
Argentina; 2 HUESPED Foundation, Buenos Aires, Argentina<br />
Background: The immune response of <strong>HIV</strong>-infected individuals<br />
shapes the evolution of the virus by selecting escape mutation.<br />
After transmission to a new host, the HLA-mediated immune<br />
pressure changes. The objective of our study was to characterize<br />
the dynamics of HLA-anchor escape mutations after transmission.<br />
Methods: We studied 6 transmission events between members<br />
of serodiscordant couples collecting blood samples from the<br />
donor and the previously seronegative-partner at the moment<br />
of seroconversion, and a second sample at least 6 months postinfection.<br />
HLA-I typing was performed by the SSOP-PCR method.<br />
The viral gene gag was amplified by RT-PCR and cloned into the<br />
pGEM-T vector for viral quasiespecies analysis. Transmitted<br />
strain was identified by phylogenetic analysis. Escape mutation<br />
was defined as viral polimorphisms located in HLA-anchor<br />
position that eliminate an epitope predicted by the NetMHC (CBS<br />
Prediction Server). Significant variations in the number of escape<br />
mutations were assessed by Poisson´s probability distribution.<br />
Results: Of the total epitopes available in transmitted gag for<br />
recognition by the recipient HLA alleles, a mean 7.25% of them<br />
selected escape mutations by the moment of the second sample<br />
collection in an anchor position of the epítope. Of the total of HLAanchor<br />
escape mutations present in the second sample and absent<br />
in the subtype consensus, a mean 79,8% were already present in<br />
the first sample of the recipient and in the sample of the donors.<br />
Also, the majority (84%) of the escape mutations to the donor’s<br />
HLA alleles persisted in time after transmission without reversion,<br />
even in the absence of the selecting HLA allele.<br />
Conclusion: The low rate of newly selected escape mutations<br />
could be due in part to lack of immune pressure, but considering<br />
the high rate of transmission and persistence, our results suggest<br />
a high level of viral adaptation to the HLA system in subtype B<br />
and recombinants BF circulating in Argentina.<br />
P05.04<br />
AIDS <strong>Vaccine</strong> 2<strong>01</strong>2<br />
Posters<br />
The Efficiency of Bridging Sheet Recruitment<br />
Determines <strong>HIV</strong>-1 R5 Envelope Sensitivity to Soluble<br />
CD4 and Macrophage Tropism<br />
O. O’Connell 6 , A. Repik 6 , J.D. Reeves 1 , M.P. Gonzalez-Perez 6 ,<br />
B. Quitadamo 6 , M. Duenas-Decamp 6 , P. Peters 6 , R. Lin 2 ,<br />
E.D. Anton 1 , S. Zolla-Pazner 3 , D. Corti 4 , A. Wallace 6 , S. Wang 6 ,<br />
X. Kong 5 , S. Lu 6 , P.R. Clapham 6<br />
1 Monogram Biosciences, San Francisco, CA, USA; 2 University<br />
of Massachusetts, Amherst, MA, USA; 3 New York University<br />
Langone School of Medicine, New York, NY, USA; 4 Humabs<br />
Biomed SA, Bellinzona, Switzerland; 5 New York University<br />
School of Medicine, New York, NY, USA; 6 University of<br />
Massachusetts Medical School, Worcester, MA, USA<br />
Background: <strong>HIV</strong>-1 R5 viruses vary extensively in their capacity<br />
to infect macrophages. R5 viruses that confer efficient infection<br />
of macrophages are able to exploit low levels of CD4 for infection<br />
and they predominate in brain tissue where macrophages are a<br />
major target for infection. <strong>HIV</strong>-1 R5 variants that are transmitted<br />
are generally non-macrophage-tropic. Here, we investigated the<br />
sensitivity of macrophage-tropic and non-macrophage-tropic R5<br />
envelopes to neutralizing antibodies.<br />
Methods: Env+ pseudovirion neutralization assays were carried<br />
out using HeLa TZM-bl cells. Envelope capture ELISAs assessed<br />
monoclonal antibody binding to monomeric gp120.<br />
Results: We observed striking differences in the sensitivity of<br />
Env+ pseudovirions to soluble CD4 compared to neutralizing<br />
monoclonal antibodies that target the CD4 binding site.<br />
Macrophage-tropic R5 envelopes were sensitive to sCD4, while<br />
non-macrophage-tropic envelopes were significantly more<br />
resistant. In contrast, all envelopes were sensitive to VRC<strong>01</strong><br />
regardless of tropism, while mab b12 conferred an intermediate<br />
neutralization pattern with all the macrophage-tropic and about<br />
half of the non-macrophage-tropic envelopes sensitive.<br />
Conclusion: CD4, b12 and VRC<strong>01</strong> share binding specificities on the<br />
outer domain of gp120. However, these reagents differ in their<br />
ability to induce conformational changes on the trimeric envelope<br />
and in specificity for residues on the V1V2 loop stem and β20-21<br />
junction that are targets for CD4 in recruiting the bridging sheet.<br />
These different binding specificities of CD4, b12 and VRC<strong>01</strong> likely<br />
explain the striking differences in envelope sensitivity to inhibition<br />
by these reagents. However, they also provide an insight into the<br />
envelope mechanisms that control macrophage-tropism. We<br />
present a model where the efficiency of bridging sheet recruitment<br />
by CD4 is a major determinant of <strong>HIV</strong>-1 R5 envelope sensitivity to<br />
soluble CD4 and macrophage tropism.<br />
165<br />
POSTERS